Stay updated on Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Sign up to get notified when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.

Latest updates to the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSite update applied: Revision v3.4.2 was added, and references to Revision v3.4.1 and a government-funding notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding status and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedUI and metadata updates include showing the glossary option, a label change to 'Last Update Submitted that Met QC Criteria', capitalization tweaks for 'No FEAR Act Data', and the addition of 'Revision: v3.4.0'. These changes are cosmetic and do not alter study content, eligibility criteria, interventions, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe only visible change is the site revision label updating from v3.3.3 to v3.3.4; no study details, eligibility criteria, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Locations section was updated to add state-level listings for California, Florida, Indiana, Louisiana, Michigan, Montana, North Carolina, Pennsylvania, Texas, and Utah, while old per-state location groupings were removed, accompanied by a new revision tag v3.3.3.SummaryDifference1.0%

- Check92 days agoChange DetectedPublications section now states items are automatically filled from PubMed and may not be about the study, with the revision labeled v3.3.2. The prior wording claiming automatic creation by ClinicalTrials.gov based on the NCT number was removed (v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.